Clinical Trial Update: Effects Of The Drug Ketoconazole On How The Body Handles The Drug SB773812 [Phase 1]

View source ↗

Summary

A Phase 1 PK interaction study evaluating how ketoconazole affects the pharmacokinetics of the investigational drug SB773812 in schizophrenia; the study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Ketoconazole (Ketoconazole)
• SB773812 (SB-773812)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED